Discovery and Characterization of ACT-335827, an Orally Available, Brain Penetrant Orexin Receptor Type1 Selective Antagonist

被引:74
作者
Steiner, Michel A. [1 ]
Gatfield, John [1 ]
Brisbare-Roch, Catherine [1 ]
Dietrich, Hendrik [1 ]
Treiber, Alexander [1 ]
Jenck, Francois [1 ]
Boss, Christoph [1 ]
机构
[1] Actel Pharmaceut Ltd, CH-4123 Allschwil, Switzerland
关键词
anxiety; neurotransmitters; orexin receptor antagonists; peptides; sleep; SLEEP; PROMOTION; SYSTEM;
D O I
10.1002/cmdc.201300003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Stress relief: Orexin neuropeptides regulate arousal and stress processing through orexin receptor type1 (OXR-1) and 2 (OXR-2) signaling. A selective OXR-1 antagonist, represented by a phenylglycine-amide substituted tetrahydropapaverine derivative (ACT-335827), is described that is orally available, penetrates the brain, and decreases fear, compulsive behaviors and autonomic stress reactions in rats. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:898 / 903
页数:6
相关论文
共 18 条
[1]  
Aissaoui H., 2001, Int. Patent, Patent No. [2001068609, WO2001068609]
[2]   The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia [J].
Bettica, Paolo ;
Squassante, Lisa ;
Zamuner, Stefano ;
Nucci, Gianluca ;
Danker-Hopfe, Heidi ;
Ratti, Emiliangelo .
SLEEP, 2012, 35 (08) :1097-1104
[3]  
Boss C., 2012, Int. PCT Pub., Patent No. [WO2012/025877 A1, 2012025877]
[4]   Orexin Receptor Antagonism: A New Principle in Neuroscience [J].
Boss, Christoph ;
Brisbare-Roch, Catherine ;
Jenck, Francois ;
Aissaoui, Hamed ;
Koberstein, Ralf ;
Sifferlen, Thierry ;
Weller, Thomas .
CHIMIA, 2008, 62 (12) :974-979
[5]   Promotion of sleep by targeting the orexin system in rats, dogs and humans [J].
Brisbare-Roch, Catherine ;
Dingemanse, Jasper ;
Koberstein, Ralf ;
Hoever, Petra ;
Aissaoui, Hamed ;
Flores, Susan ;
Mueller, Celia ;
Nayler, Oliver ;
van Gerven, Joop ;
de Haas, Sanne L. ;
Hess, Patrick ;
Qiu, Changbin ;
Buchmann, Stephan ;
Scherz, Michael ;
Weller, Thomas ;
Fischli, Walter ;
Clozel, Martine ;
Jenck, Francois .
NATURE MEDICINE, 2007, 13 (02) :150-155
[6]   Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia [J].
Cox, Christopher D. ;
Breslin, Michael J. ;
Whitman, David B. ;
Schreier, John D. ;
McGaughey, Georgia B. ;
Bogusky, Michael J. ;
Roecker, Anthony J. ;
Mercer, Swati P. ;
Bednar, Rodney A. ;
Lemaire, Wei ;
Bruno, Joseph G. ;
Reiss, Duane R. ;
Harrell, C. Meacham ;
Murphy, Kathy L. ;
Garson, Susan L. ;
Doran, Scott M. ;
Prueksaritanont, Thomayant ;
Anderson, Wayne B. ;
Tang, Cuyue ;
Roller, Shane ;
Cabalu, Tamara D. ;
Cui, Donahui ;
Hartman, George D. ;
Young, Steven D. ;
Koblan, Ken S. ;
Winrow, Christopher J. ;
Renger, John J. ;
Coleman, Paul J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) :5320-5332
[7]   Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant [J].
Dietrich, Hendrik ;
Jenck, Francois .
PSYCHOPHARMACOLOGY, 2010, 212 (02) :145-154
[8]   Hypocretin /orexin contributes to the expression of some but not all forms of stress and arousal [J].
Furlong, Teri M. ;
Vianna, Daniel M. L. ;
Liu, Lu ;
Carrive, Pascal .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2009, 30 (08) :1603-1614
[9]   International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology [J].
Gotter, Anthony L. ;
Webber, Andrea L. ;
Coleman, Paul J. ;
Renger, John J. ;
Winrow, Christopher J. .
PHARMACOLOGICAL REVIEWS, 2012, 64 (03) :389-420
[10]   Tetrahydroisoquinolines as orexin receptor antagonists: Strategies for lead optimization by solution-phase chemistry [J].
Koberstein, R ;
Aissaoui, H ;
Bur, D ;
Clozel, M ;
Fischli, W ;
Jenck, F ;
Mueller, C ;
Nayler, O ;
Sifferlen, T ;
Treiber, A ;
Weller, T .
CHIMIA, 2003, 57 (05) :270-275